Consistent with this notion, CD44+ PCa/HPCa cells, although possessing high clonogenic, tumour-regenerating and metastatic potentials13, 20, 21, 23, 25, did not manifest a ‘pure' mesenchymal gene expression profile (Supplementary Fig. 4f–j). The gene discussed is CD44; the disease is posterior cortical atrophy.